Varying potency of self and cancer peptides in KIR3DL1 recognition of HLA-A*24:02 — ASN Events
  1. Schedule
  2. Poster Session One
  3. Varying potency of self and cancer peptides in KIR3DL1 recognition of HLA-A*24:02

Varying potency of self and cancer peptides in KIR3DL1 recognition of HLA-A*24:02 (#106)

Shaghik Barani 1 , Andrew Brooks 2 , Jamie Rossjohn 1 3
  1. Infection and Immunity Program, Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
  2. Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria, Australia
  3. Institute of Infection and Immunity, School of Medicine, Cardiff University, UK, Cardiff, United Kingdom
Publish consent withheld
  1. Saunders PM, Pymm P, Pietra G, Hughes VA, Hitchen C, O'Connor GM, Loiacono F, Widjaja J, Price DA, Falco M, Mingari MC, Moretta L, McVicar DW, Rossjohn J, Brooks AG, Vivian JP. Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med. 2016 May 2;213(5):791-807. doi: 10.1084/jem.20152023. Epub 2016 Apr 4. PMID: 27045007; PMCID: PMC4854737.